Training activity information
Details
Discuss with a prospective donor the initial genetic testing required for screening and how commercial ancestral testing changes the understanding of anonymity
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee​.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
- The implications of commercial genetic testing for anonymity, personal understanding of own family relationships and awareness of disease risk
- Tests for genetic disease, consent and outcomes
- Requirements for informed consent to genetic testing
- The role of the Genetic Counsellor and Clinical Geneticist in delivery and discussion of adverse results
- Pre-implantation genetic testing (PGT) options
- Communication of complex information to non-experts
- Two-way communication to ensure patient awareness
Reflective practice guidance
The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.
Before action
- What initial genetic tests are typically required for sperm donor screening?
- What are the current regulations relating to donor anonymity, and how has commercial ancestral testing impacted on this?
- What information do you need to know about relevant genetic tests and the implications of ancestral testing?
- What insights do you hope to gain in explaining genetic testing procedures and the evolving challenges to donor anonymity?
- What do you already know about these topics?
- What challenges might arise in explaining complex genetic concepts and the implications of readily available ancestral testing?
- How will you address potential concerns about anonymity?
- How do you feel about discussing the intersection of genetics and personal identity?
In action
- Focus on how you are discussing the initial genetic testing required for screening with a prospective donor. What tests are you explaining, and why are they necessary? How are you explaining the implications of commercial ancestral testing on anonymity?
- What decisions are you making about the level of technical detail to include and how to explain potentially complex concepts in an accessible way?
- What aspects of explaining genetic testing and its implications feel routine, and what requires more careful consideration to ensure the donor fully understands the information, especially regarding anonymity?
- How effective is your explanation in ensuring the prospective donor understands the purpose and implications of the required genetic testing and the impact of commercial ancestral testing? How are you gauging their comprehension?
- What challenges are you encountering in explaining these technical aspects clearly and addressing potential concerns about anonymity?
- What are you learning about communicating genetic information to non-genetics professionals and the public?
- How does this discussion contribute to the process of preparing and guiding donors through the sperm donation programme and ensuring the safety of the process?
- If the donor has specific questions or expresses concerns about the genetic testing or anonymity, how are you adjusting your explanation and providing reassurance?
- What support or resources might you need if you struggle to explain a particular genetic test or its implications?
- Are you ensuring that the discussion is conducted ethically and in accordance with relevant guidelines regarding genetic testing and donor anonymity?
On action
- What information did you provide about the specific initial genetic tests required for screening?
- How did you explain the purpose and limitations of these tests?
- How did you discuss the potential impact of commercial ancestral testing on donor anonymity?
- What were the prospective donor’s views and understanding of these issues?
- How to explain the rationale and process of initial genetic testing for sperm donors in a clear and understandable manner?
- How to discuss the complex issue of donor anonymity in the context of readily available commercial ancestral testing?
- What are the ethical and practical implications of this evolving landscape for sperm donation programmes?
- How does providing this information contribute to informed consent and ethical practice?
- Do you need to update your knowledge on the specific genetic tests used for initial donor screening or the latest developments in commercial ancestral testing and their implications for anonymity?
- How will you approach future discussions with prospective donors on these sensitive and evolving topics?
- What resources (e.g., guidelines on genetic testing and anonymity, information on commercial ancestry services) will you use in your practice?
Beyond action
- Have you revisited your experience of discussing initial genetic testing and the implications of commercial ancestral testing with prospective donors?
- Have you had further discussions about genetic testing with donors?
- Has your understanding of the genetic testing required for screening evolved?
- How has your awareness of the impact of commercial ancestral testing on anonymity changed?
- How has this experience impacted your current practice in guiding donors, ensuring ethical practice, and communicating with the team?
- Has this training activity influenced how you prepare and guide donors through the genetic testing process?
- How has it informed your practice in accordance with best practice guidance and regulations regarding anonymity?
- Has it enhanced your communication skills when discussing complex genetic information?
- Has it highlighted the importance of discussing these aspects with the multidisciplinary team?
- What did you learn about communicating complex genetic concepts and the evolving understanding of anonymity in donation?
- How has this experience informed your ethical considerations in the context of genetic information and gamete donation?
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 4 |
Outcome
Prepare and guide donors and recipients through the sperm donation process. |
| # 6 |
Outcome
Practice safely in accordance with best practice guidance and regulations. |
| # 7 |
Outcome
Apply and adapt skills to communicate effectively with patients and the multidisciplinary team. |
| # 8 |
Outcome
Practice in partnership with the multidisciplinary team and other clinical specialties in the investigation and management of patients referred to andrology services. |